About Herba Healthcare

Our mission is to be at the forefront of the development and registration of cannabis-based medicine in Australia and around the world.

Company Overview

Herba Healthcare is considered one of the global leaders in high-quality phytopharmaceutical cannabis with an existing medical product line, proprietary genetics and high-end Swiss cultivation and production facilities. Herba is part of the Medropharm group of companies and is a full provider of end-to-end cannabis solutions from farming to extracts and formulations to pharmaceutical GMP products.

The main cornerstone in Herba’s business model is to continue to develop medical cannabis products and research the cannabinoid profile. By leveraging our existing experience and utilising world-class universities via our partnership program, we can push forward research and swiftly act to commercialise IP, medicines, and drug delivery systems.

Our Business

We do not sell retail cannabis products – our business is strictly pharmaceutical grade medical cannabis only.

Herba Healthcare Australia was established to provide Australian medical professionals, hospitals and patients access to a standardized high-quality supply of pharmaceutical grade cannabis.

Herba Healthcare has partnered with Medropharm (Switzerland), enabling Herba Healthcare to acquire the rights to sell and distribute Medropharm’s globally selling product line in Australia and New Zealand.

Our products come directly from the manufacturer in Switzerland and are produced in a pharmaceutical GMP certified facility that is currently sold in hospitals, pharmacies and by medical professionals across the globe.

Herba Healthcare’s intense global medical focus on registering medicines will transform our company into the worldwide leader in phytopharmaceutical products.

Herba Healthcare and Medropharm have extensive know-how and experience in cultivation and extraction with a capacity of over 30ha of greenhouse facilities. Our growing facilities are one of the largest in Europe and we currently wholesale to some of the largest cannabis companies in the world.

Our Business

We do not sell retail cannabis products – our business is strictly pharmaceutical grade medical cannabis only.

 

Herba Healthcare has partnered with Medropharm (Switzerland) and Greenfield's (Uruguay), enabling Herba Healthcare to acquire the rights to sell and distribute Medropharm’s globally selling product line in Australia and New Zealand.

Our products come directly from the manufacturer in Switzerland and is produced in a pharmaceutical GMP certified facility that are currently sold in hospitals, pharmacies and by medical professionals across the globe.

Herba Healthcare’s intense medical focus on registering medicines globally will transform our company into the global leader in phytopharmaceutical products.

Herba Healthcare and Medropharm have extensive know-how and experience in cultivation and extraction with a capacity of over 30ha of greenhouse facilities. Our growing facilities are one of the largest in Europe and we currently wholesale to some of the largest cannabis companies in the world.  

Our Team

The team at Herba consists of people that are passionate about helping the cannabis industry grow and mature but more importantly improving quality of life and achieving real results for patients in need.

We operate on a global basis with an experienced team of cannabis professionals that include medical professionals, scientists, pharmacists, and cultivation and grow experts, successful entrepreneurs and investors. We are a large team working in synergy to realise our vision and reach our strategic goals in the cannabis space.

Executive Managment Australia


Executive Management Switzerland

Dr. Claudia Zieres-Nauth – CEO and Partner
As a human biologist she was e.g. at Roche responsible for development projects or as a senior executive leading the global launch and commercialization of new products. She has now taken on the position of CEO at Medropharm and is also responsible for medical management and clinical studies.

Patrick Widmer – CBDO and Partner
Agribusiness executive and marketing specialist. Entrepreneur with a background in Marketing and Communication. Has strong experience in agribusiness and management consulting, providing services in corporate governance, management and as a corporate accountant.

Oliver Tschäppät – R&D Officer and Partner
Oliver is one of the founders of Medropharm GmbH. He has a background in food technology and worked 4 years for Givaudan, the world´s leading flavour and fragrance company. He is in charge of R&D at Medropharm.

Mike Toniolo – Sales Officer and Partner
Mike has more than 5 years of senior executive experience in the Cannabis sector as a founder, executive and board member. His focus lays in production processes including the development of cannabis facilities as well as in genetic development of cannabis strains.

 


Executive Management South America

Gaston Rodriguéz Lepera – CEO
Industrial Designer with years of experience and responsible for the cannabis regulation in Uruguay.

Sthefan Ferrari Negraes Consorte – CEO
Lawyer specialized in corporate, banking and regulatory law.

Fernando Henrique Göltl – CSO
Biology graduate specialized in drug policies and regulatory assistance concerning medicinal Cannabis.

Heitor Cintra Valdivia Pineda – CFO
Economist specialized in projects development, econometrics, real options and accounting analyses.


Independent Consultants
(actively involved in Epilepsy preclinical trials in Brazil)

Carlos Rocha de Oliveira
Master's degree in Pharmacology and a Ph.D. in Biotechnology. Professor and coordinator of Photographics at Anhembi Morumbi University, has experience in the field of Pharmacology, with emphasis on the Mode of Drug Action.

Daniel Moreno Garcia
University professor and researcher with a doctorate in pharmacology at the Universidade Federal de São Paulo (UNIFESP). Specialized in pharmacological development and tumor treatment research.

Renato Filev
Biomedical Sciences graduate and Ph.D. in Neuroscience by UNIFESP/EPM. Member of the Program of Orientation and Treatment of Addiction PROAD/UNIFESP.